Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes: Assessment of Vaccine Selection and Outcomes for the Follow-on Study Year

NCT03599739 is registered in ClinicalTrials.gov with Insight Therapeutics, LLC as lead sponsor.

NCT NCT03599739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03599739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes: Assessment of Vaccine Selection and Outcomes for the Follow-on Study Year
Lead sponsor
Insight Therapeutics, LLC
Phase
Observational
Overall status
Completed
Start date
July 13, 2018
Completion date
January 25, 2023
Enrollment
598 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza, human, influenza-like illness